Physician profile
Chad Wilson
NPI 1386628949
$1,363.39
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $11.38 · 2021: $670 · 2023: $17.98 · 2024: $70.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $594.69 | 2021 | |
| Davol INC. | $346.55 | 2019-2020 | |
| Tela Bio, INC. | $175.88 | 2019-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Portola Pharmaceuticals, LLC | $63.89 | 2019 | |
| Pfizer INC. | $58.00 | 2019 | |
| Z-Medica, LLC | $44.94 | 2019 | |
| Smith+Nephew, INC. | $31.18 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $25.06 | 2019 | |
| Allergan, INC. | $23.20 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.